Andy Quintenz leads the Scientific & Professional Affairs team for Bio-Rad’s Quality Systems Division. He is a member of the American Association for Clinical Chemistry (AACC) Corporate Advisory Board, the Industry Liaison to the federally mandated Clinical Laboratory Improvements Advisory Committee (CLIAC), Chair of the US Technical Advisory Group to ISO TC 212 (Clinical Laboratory Testing and In Vitro Diagnostic Test Systems, and a member of the AdvaMed Diagnostic Task Force.
With 25 years of medical device industry experience, his work now focuses on improving the quality of laboratory testing worldwide by promoting an understanding of quality control/quality assurance best practices and laboratory regulations. Andy has been involved with CLSI in various capacities during his career, including serving as an inaugural member of the CLSI Consensus Council. He finds volunteer work meaningful, and during his international travel for Bio-Rad, enjoys promoting the role CLSI documents play in laboratory quality.